Peptide Skincare & BeautySkin science and ingredient guides

Skin science article

GHK-Cu Peptide Therapy Denver | R2 Medical Clinic

GHK-Cu What Is GHK-Cu? GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding tripeptide composed of the amino acids glycine, histidine, and lysine complexed with copper (Cu²⁺). It was first isolated from human plasma in the 1970s a

By Peptide Skincare & Beauty Editorial TeamPublished

GHK-Cu

What Is GHK-Cu?

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding tripeptide composed of the amino acids glycine, histidine, and lysine complexed with copper (Cu²⁺). It was first isolated from human plasma in the 1970s and has since been identified in saliva and urine. GHK levels naturally decline with age.

GHK-Cu has been extensively studied for its potential role in skin remodeling, wound healing, collagen synthesis, tissue regeneration, angiogenesis, antioxidant activity, and anti-inflammatory effects. Because of these biologic properties, GHK-Cu has become a common ingredient in topical cosmetic formulations and has also been investigated as an injectable peptide for regenerative medicine.

Although laboratory and early clinical studies are encouraging, GHK-Cu is not FDA-approved as an injectable drug for any medical indication in the United States. The FDA has identified safety concerns regarding compounded injectable GHK-Cu because of limited human safety data and the potential for peptide impurities and immunogenicity.

Mechanism of Action

GHK-Cu functions as both a copper transport peptide and a regulator of numerous cellular repair pathways.

Research suggests GHK-Cu may:

Deliver bioavailable copper to cells

Stimulate collagen, elastin, and glycosaminoglycan synthesis

Promote fibroblast proliferation

Enhance angiogenesis (new blood vessel formation)

Accelerate epithelial and connective tissue repair

Modulate inflammatory cytokines

Reduce oxidative stress

Influence expression of thousands of genes involved in tissue remodeling and healing

Support stem cell signaling and extracellular matrix remodeling

Unlike many growth factor therapies, GHK-Cu appears to regulate multiple repair pathways simultaneously rather than acting through a single receptor. Much of this mechanistic evidence comes from laboratory and preclinical studies.

Potential Benefits

Published research suggests GHK-Cu may provide several biologic effects.

Potential benefits may include:

Improved skin quality

Increased collagen production

Increased elastin synthesis

Improved skin firmness and elasticity

Reduction in fine lines and photoaging

Enhanced wound healing

Promotion of angiogenesis

Support of hair follicle function

Reduction of oxidative stress

Anti-inflammatory activity

Support of connective tissue repair

Potential support for nerve regeneration in experimental models

While several placebo-controlled cosmetic studies have demonstrated improvements in aging skin, most proposed systemic or injectable uses remain investigational and are supported primarily by laboratory and animal data rather than large randomized clinical trials.

Risks & Side Effects

Topical GHK-Cu has generally demonstrated a favorable safety profile in cosmetic studies.

Potential adverse effects include:

Local skin irritation

Redness

Itching

Contact dermatitis

Injection-site reactions (injectable formulations)

Headache

Hypersensitivity reactions

Local swelling

Unknown long-term systemic safety

Potential immunogenicity associated with compounded injectable products

The FDA has specifically noted that compounded injectable GHK-Cu may pose safety concerns because of peptide aggregation, impurities, and limited human safety data.

Contraindications

GHK-Cu should generally be avoided or used only with caution in individuals with:

Known hypersensitivity to copper peptides

Pregnancy or breastfeeding (limited safety data)

Active malignancy until cleared by an oncologist

Wilson disease or other disorders of copper metabolism

Active skin infection at treatment sites

Use of non-sterile or unregulated injectable peptide products

Patients with chronic illnesses or complex medical conditions should consult a qualified healthcare provider before considering GHK-Cu therapy.

FDA Approval Status

Injectable GHK-Cu

GHK-Cu is not FDA-approved for any injectable medical indication in the United States.

The FDA has identified safety concerns regarding compounded injectable GHK-Cu because available human safety information is limited and compounded preparations may present risks related to immunogenicity and peptide impurities.

Topical Cosmetic Products

Copper peptides, including GHK-Cu, are commonly used in cosmetic skincare products marketed to improve the appearance of aging skin. These cosmetic products are regulated differently than prescription drugs and should not be interpreted as FDA approval for medical treatment.

Human & Animal Studies

Human Studies

Human clinical research has focused primarily on skin aging and wound healing.

Published studies have demonstrated that topical GHK-Cu may:

Improve skin elasticity

Increase collagen production

Improve skin density

Enhance wound healing

Improve overall skin appearance

Support remodeling of photoaged skin

Small placebo-controlled clinical studies have reported improvements in skin quality among middle-aged women following topical GHK-Cu treatment. However, evidence supporting injectable or systemic use remains limited, and large randomized clinical trials are lacking.

Animal & Preclinical Studies

Animal and laboratory studies have demonstrated that GHK-Cu may:

Accelerate wound healing

Promote angiogenesis

Increase collagen and elastin synthesis

Reduce inflammatory signaling

Improve nerve regeneration

Promote hair growth in experimental models

Improve bone and connective tissue repair

Influence expression of numerous genes involved in tissue regeneration

These findings provide biologic plausibility but do not establish clinical efficacy for common off-label injectable uses in humans.

Published Studies

Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Datahttps://pubmed.ncbi.nlm.nih.gov/29986520/

Regenerative and Protective Actions of the GHK-Cu Peptide (Full Text)https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/

GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regenerationhttps://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/

Topical GHK-Cu Gel for Acute Skin Wound Healing (Phase 2 Clinical Trial)https://clinicaltrials.gov/study/NCT07437586

The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Cognitive Declinehttps://pubmed.ncbi.nlm.nih.gov/22666519/

The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress (Full Text)https://pmc.ncbi.nlm.nih.gov/articles/PMC3359723/

The Potential of GHK as an Anti-Aging Peptidehttps://pubmed.ncbi.nlm.nih.gov/35083444/

The Potential of GHK as an Anti-Aging Peptide (Full Text)https://pmc.ncbi.nlm.nih.gov/articles/PMC8789089/

GHK and DNA: Resetting the Human Genome to Healthhttps://pmc.ncbi.nlm.nih.gov/articles/PMC4180391/

The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Functionhttps://www.mdpi.com/2076-3425/7/2/20

The information provided on this page is intended for educational and informational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease and should not be considered medical advice.

This content was generated with the assistance of artificial intelligence (AI) and should be reviewed by a qualified medical professional before publication or clinical use. AI-generated medical content may contain errors, omissions, or outdated information.

GHK-Cu is not FDA-approved as an injectable drug for any medical indication in the United States. While topical copper peptide products are widely used in cosmetic skincare, injectable GHK-Cu remains investigational. Individual results vary, and no specific outcome or benefit can be guaranteed. Patients should consult a qualified healthcare provider before beginning or changing any medical treatment.

R2 Medical Clinic uses medications sourced from compounding pharmacies. Compounded medications are not approved by the U.S. Food and Drug Administration (FDA). Unlike FDA-approved medications, compounded drugs have not undergone FDA review for safety, effectiveness, or efficacy through the FDA drug approval process. While 503B outsourcing facilities are registered with and inspected by the FDA and must comply with Current Good Manufacturing Practice (CGMP) requirements, the compounded medications they produce are not individually approved by the FDA. Similarly, compounded medications prepared by 503A pharmacies are not FDA-approved and are primarily regulated by state boards of pharmacy, with FDA oversight under applicable federal law.

# MOTS-c

The reference edit

Ingredients, questions
& further reading.

Connected source records selected through this article’s public topic index.

01

Formula cabinet

Ingredients & structured notes

Ingredient index

Can GHK-Cu be used with other active ingredients like Vitamin C or Retinol?

  1. 01Yes, GHK-Cu is generally compatible with many other active ingredients. However, we advise applying GHK-Cu first, allowing it to absorb, before applying stronger actives like high-concentration Vitamin C or Retinol. This approach helps minimize pote…
Source · realpeptides.co ⟶
02

Product index

Related product references

Product

Lovely Southern GHK-Cu Repair Serum

Lovely Southern GHK-Cu Repair Serum Ingredients in Lovely Southern GHK-Cu Repair Serum explained: benefits, concerns, and detailed analysis of 9 ingredients including Water, Sodium Hyaluron…

Source: skinsort.comView reference →
03

Comparison edit

Read side by side

GHK-Cu Product Comparison: Key Considerations

Purity & Synthesis Often mass-produced, lower purity, unknown synthesis methods. Impurities can reduce efficacy or cause irritation. Small-batch synthesis, exact amino-acid sequencing, guar…

04

Ask the journal

Related questions

01What If You're Using It Alongside Retinoids or Vitamin C?

Combine GHK-Cu with retinoids cautiously. Both upregulate collagen synthesis but through different pathways (GHK-Cu via integrin signaling, retinoids via retinoic acid receptors). The inflammation from retinoid use can temporarily increase MMP expression, which GHK-Cu suppresses. Creating a push-pull effect during the first 4–6 weeks. Apply retinoid at night and GHK-Cu in the morning, or alternate days during the initial titration phase. Vitamin C (L-ascorbic acid) at pH 3–3.5 can destabilize copper coordination if mixed directly; use them in separate formulations at different times of day.

Source · realpeptides.co ⟶
02What if I combine GHK-Cu with microneedling to increase penetration — is that safe?

Combining them is mechanistically sound but requires careful timing. Microneedling creates controlled micro-injuries that enhance peptide penetration, but applying GHK-Cu immediately post-needling on compromised barrier can cause excess copper uptake and localized irritation. A safer protocol: microneedle first, wait 24–48 hours for barrier recovery, then resume GHK-Cu application. Some dermatology practices use this exact sequence. Needle every four weeks, GHK-Cu daily between sessions.

Source · realpeptides.co ⟶
03What If GHK-Cu Shows No Effect in Cell Culture — Is the Peptide Inactive?

Verify copper content first. Peptide purity alone does not guarantee activity. If copper dissociation has occurred (due to pH extremes, prolonged storage at room temperature, or lyophilization without stabilizers), you're testing inactive peptide. Atomic absorption spectroscopy or inductively coupled plasma mass spectrometry (ICP-MS) can confirm copper:peptide stoichiometry. Second, confirm that your cell line expresses the pathways GHK-Cu modulates. Fibroblasts, keratinocytes, and endothelial cells are most responsive. Cell lines with minimal extracellular matrix production may not show robust effects regardless of peptide quality.

Source · realpeptides.co ⟶
04What If I Apply GHK-Cu Immediately After Surgery?

Wait 24 hours. The body's initial inflammatory response serves a protective function. It clears debris, prevents infection, and recruits immune cells to the wound site. Applying GHK-Cu during this phase may blunt that response prematurely. The 2021 Plastic and Reconstructive Surgery trial found that patients who started GHK-Cu immediately post-op showed only 8% improvement over placebo, while those who started at 24 hours saw 34% improvement. Let inflammation run its course for the first day, then introduce the peptide.

Source · realpeptides.co ⟶
05What If Animal Neuroregeneration Data Translates to Humans?

It might, but current evidence is limited to case reports. The Barrow Institute rodent data showing 34% faster axonal regrowth used direct nerve injection. Not feasible in most human contexts. The one published diabetic neuropathy case series used topical application and measured only subjective pain scores, not objective nerve conduction velocity. Translating the animal mechanism (NGF receptor upregulation on Schwann cells) to humans would require subcutaneous administration near affected nerves, which hasn't been studied in controlled trials. If neuroregeneration is the goal, animal data establishes plausibility but doesn't provide a validated human protocol yet.

Source · realpeptides.co ⟶
05

Source shelf

Research & excerpts

Research note

GHK-Cu and Inflammation Studies

GHK has been isolated in urine, saliva and plasma. It occurs naturally, and appears to form complexes with copper readily, and may regulate the metabolism of the copper. The copper (II) chelation and the GHK tripeptide, together form the GHK-Cu, may accelerate the processes of wound healing, regeneration, anti-inflammatory actions and anti-oxidant potential. The level of the TNF-α and TGF-β, the acute phase inflammatory cytokines, may be lowered following GHK-Cu exposure, thereby resulting in the oxidative damage and hence, the suppression of inflammation. In one research study, it was suggested that the GHK-Cu exposure to the animal models increased the superoxide dismutase and decreased the production of the reactive oxygen species. Also the production of IL-6 and TNF-α appeared to be decreased as a result of the suppression of the p39 MAPK and NF-κB p65 in the in-vitro model. The results of the studies have suggested that the LPS-induced phosphorylation of NF- κB p65 may be also inhibited by GHK-Cu. Additional studies have reported that the GHK-Cu may potentially inhibit the NF-κB pathway in inflammatory bowel diseases and chronic inflammatory diseases. With all these points, it has been suggested by researchers that the GHK-Cu has the potential to improve the growth of hair follicles, as it appears to reduce the negative impacts such as inflammation and iron toxicity, and may promote processes such as cell proliferation and blood circulation close to the site of follicle development.

Source · biotechpeptides.com ⟶

Continue reading

Related articles